MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENTOption and Research License Agreement • March 17th, 2015 • Lightlake Therapeutics Inc. • Metal mining • New York
This Material Transfer, Option and Research License Agreement (the “Agreement”) dated as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Lightlake Therapeutics, Inc. (“Lightlake”), having a place of business at 96-98 Baker Street, First Floor, London, UK, W1U 6TJ.
MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENTOption and Research License Agreement • May 5th, 2020 • New York
This Material Transfer, Option and Research License Agreement (the “Agreement”) dated as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Lightlake Therapeutics, Inc. (“Lightlake”), having a place of business at 96-98 Baker Street, First Floor, London, UK, W1U 6TJ.
MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENTOption and Research License Agreement • June 12th, 2015 • Lightlake Therapeutics Inc. • Metal mining • New York
This Material Transfer, Option and Research License Agreement (the “Agreement”) dated as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Lightlake Therapeutics, Inc. (“Lightlake”), having a place of business at 96-98 Baker Street, First Floor, London, UK, W1U 6TJ.
